» Articles » PMID: 22943310

Early Molecular Responses of Bone to Obstructive Nephropathy Induced by Unilateral Ureteral Obstruction in Mice

Overview
Specialty Nephrology
Date 2012 Sep 5
PMID 22943310
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This study was performed to address the bone injury and the early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice.

Methods: The male mice were subjected to unilateral ureteral obstruction (UUO, n = 10) or sham operation (n = 10). All mice were killed on day 7 after the surgical operation. Hematoxylin and eosin and tartate-resistant acid phosphatase staining were performed on paraffin-embedded bone sections. Expression of genes and proteins was analyzed by reverse transcription-polymerase chain reaction, and Western blotting and immunohistochemistry staining, respectively.

Results: The serum calcium level was significantly reduced in UUO mice compared with that of Sham mice. The proximal tibia of UUO mice exhibited the increased expansion of chondrocytes zone, the reduction of osteoid content, and the increased separation and disconnection of woven bones. Reverse transcription-polymerase chain reaction results showed the downregulation of Cbfa1 and Col mRNA expression and the upregulation of Tgf-β, CtsK, CaII, Opg and Rankl mRNA expression in tibia of UUO mice compared to those of Sham mice. The ratio of Opg and Rankl was unchanged between Sham and the UUO group. Local protein expression of angiotensin II and its type 2 receptor was dramatically upregulated in tibia of UUO mice.

Conclusion: Together, it is concluded that the obstructive nephropathy has defective effects on bone, and the underlying mechanisms are the reduction of bone formation and the increase of bone resorption, which is mediated, at least partially through local angiotensin II signalling.

Citing Articles

Angiotensin II Modulates Calcium/Phosphate Excretion in Experimental Model of Hypertension: Focus on Bone.

Castoldi G, Carletti R, Ippolito S, Villa I, Palmisano B, Bolamperti S Biomedicines. 2022; 10(11).

PMID: 36428495 PMC: 9687632. DOI: 10.3390/biomedicines10112928.


Type I Angiotensin II Receptor Blockade Reduces Uremia-Induced Deterioration of Bone Material Properties.

Wakamatsu T, Iwasaki Y, Yamamoto S, Matsuo K, Goto S, Narita I J Bone Miner Res. 2020; 36(1):67-79.

PMID: 32786093 PMC: 9328427. DOI: 10.1002/jbmr.4159.


Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice.

Chen X, Li X, Liu J, Xu J, Zhao Y, Yang M Pharmacol Rep. 2018; 70(4):705-711.

PMID: 29933208 PMC: 7102314. DOI: 10.1016/j.pharep.2018.02.008.


Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis.

Abuohashish H, Ahmed M, Sabry D, Khattab M, Al-Rejaie S Sci Rep. 2017; 7(1):2293.

PMID: 28536469 PMC: 5442122. DOI: 10.1038/s41598-017-02570-x.


Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.

Zhang Y, Wang L, Song Y, Zhao X, Wong M, Zhang W Osteoporos Int. 2015; 27(3):1083-1092.

PMID: 26439241 DOI: 10.1007/s00198-015-3348-y.